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Introduction
Normal saline solution has been used for over 50 years in 
a multitude of clinical situations as an intraoperative, 
resus  citation and maintenance ﬂ   uid therapy. Neither 
normal nor physiological, however, saline solution is still 
a standard against which other solutions are measured. 
Much attention has been given recently to so-called 
balanced solutions such as Ringer’s lactate, and more 
recent derivatives. Colloids prepared in balanced 
electrolyte solutions have also been developed, alongside 
colloids in isotonic saline.
As one might expect, excessive use of saline has been 
observed to result in hyperchloraemic acidosis – which 
has been identiﬁ  ed as a potential side eﬀ  ect of saline-
based solutions. Th  ere is debate about the morbidity 
associated with this condition, although some consider 
the associated morbidity is probably low. It has been 
suggested that the use of balanced solutions may avoid 
this eﬀ  ect.
Th   is acidosis eﬀ  ect was reviewed and highlighted in the 
British Consensus Guidelines on Intravenous Fluid 
Th   erapy for Adult Surgical Patients [1]. Th  ese  guidelines 
clearly recommend the use of balanced crystalloids 
rather than saline – but they make no speciﬁ  c recom-
men  dations regarding colloids, implying that they could 
be either standard or balanced. Th   e publication of these 
guidelines has provoked strong reactions. In a British 
Medical Journal editorial, Liu and Finfer comment: 
‘Although administration of normal saline can cause 
hyperchloraemic acidosis, we do not know whether this 
is harmful to patients. Adopting this guideline is unlikely 
to harm patients, but may not have any tangible beneﬁ  t’ 
[2].
Others have reviewed the physiological eﬀ  ects  of 
acidosis. Handy and Soni noted that ‘Th  ere is little 
evidence that in 50 years of normal saline usage, there 
has been signiﬁ  cant morbidity from the use of this ﬂ  uid’ 
[3]. Liu and Finfer continue: ‘Th  e danger in providing 
consensus guidelines endorsed by specialist societies is 
that clinicians may feel pressured to adopt interventions 
that may, in the longer term, be found to cost more and 
to do more harm than good. We agree with the recently 
expressed view that unless recommendations are based 
on high quality primary research, then perhaps guidelines 
should be avoided completely, and clinicians would be 
better oﬀ    making clinical decisions on the basis of 
primary data’ [4].
Given the obvious controversy that exists based on the 
interpretation of the available information, the entire 
topic should clearly be reviewed again. Accordingly, the 
present article reviews the available literature comparing 
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crystal  loids and colloids) and investigates the scientiﬁ  c 
basis that should be taken into account in any future 
guidelines or recommendations.
The acid–base equilibrium: Henderson–Hasselbalch 
versus Stewart
It is vital to determine the mechanism for an acid–base 
disturbance in critically ill patients in order to administer 
appropriate treatment. Th  e  Henderson–Hasselbalch 
equation is still the standard method for interpreting 
acid–base equilibrium in clinical practice [5]:
pH = pK1΄ + log[HCO3
–] / (S x PCO2)
Th   is equation describes how plasma CO2 tension, plasma 
bicarbonate (HCO3
–) concentration, the apparent disso-
ciation constant for plasma carbonic acid (pK) and the 
solubility of CO2 in plasma interact to determine plasma 
pH. Th   e magnitude of the metabolic acidosis is generally 
quantiﬁ  ed by the base deﬁ  cit or base excess, which is 
deﬁ  ned as the amount of base (or acid) that must be 
added to a litre of blood to return the pH to 7.4 at a 
partial pressure of carbon dioxide (PCO2) of 40 mmHg. 
Th   e main conse  quence of infusion of isotonic saline is a 
dilution of bicar  bo  nate. Th   e dilution of albumin may also 
play a minor role. Accordingly, the observed disorder is 
reported as a dilutional acidosis, associating a base deﬁ  cit 
with a high chloride concentration.
A diﬀ  erent approach (the strong ion approach) to acid–
base equilibrium was developed in 1983 by Stewart to 
account for ﬂ   uctuation of the variables that indepen-
dently regulate plasma pH [6]. He proposed that plasma 
pH is aﬀ  ected by three independent factors: PCO2; the 
strong ion diﬀ   erence (SID), which is the diﬀ  erence 
between the charge of plasma strong cations (sodium, 
potassium, magnesium and calcium) and strong anions 
(chloride, sulphate, lactate and others); and the sum of all 
anionic charges of weak plasma acids (Atot), which is the 
total plasma concentration of nonvolatile buﬀ  ers (albumin, 
globulins, phosphate). More advanced explanations are 
available in a recent review by Yunos and colleagues [7].
Th   e Stewart equation may be written in a similar form to 
the Henderson–Hasselbalch equation [8]:
pH = pK1΄ + log[SID – Atot / (1 + 10pKa – pH)] / (S x PCO2)
At the usual pH of plasma, part of the albumin complex 
carries a negative charge, which could therefore play a 
role in buﬀ  ering H+ ions. Th   e same applies to phosphate, 
although the concentration of phosphate in the plasma is 
too low to provide signiﬁ  cant buﬀ  ering. Accordingly, the 
Stewart approach emphasises the role of albumin, 
phosphate and other buﬀ  ers in acid–base equilibrium. 
Th   e Stewart approach can distinguish six primary acid–
base disturbances instead of the four diﬀ  erentiated by the 
Henderson–Hasselbalch equation. Th   is strong ion 
approach also provides a more comprehensive explana-
tion of the role of chloride in acid–base equilibrium.
Th   e SID of isotonic saline being 0, the infusion of large 
quantities will dilute the normal SID of plasma and 
decrease pH. Hyperchloraemic metabolic acidosis is 
there  fore a decrease in SID associated with an increase in 
chloride. Th  e Stewart equation also shows that the 
infusion of isotonic saline will also dilute albumin and 
decrease Atot, which tends to increase pH. Using the 
Stewart equation, a balanced solution with a physiological 
SID of 40 mEq/l would induce a metabolic alkalosis. 
Morgan and Venka  tesh have calculated that a balanced 
solution should have a SID of 24 mEq/l in order to avoid 
this induction [9]. It should be noted that balanced 
solutions using organic anions (such as lactate, acetate, 
gluconate, pyruvate or malate) have an in vitro SID equal 
to 0, similar to isotonic saline. In vivo, the metabolism of 
these anions increases the SID and also decreases the 
osmolarity of the solution.
Th   is equation, while comprehensive, is still complex for 
common use if used in its entirety, but a simpliﬁ  ed 
Stewart approach can be used to make a graphical inter-
pretation of the acid–base equilibrium. Th  is approach 
takes into account the eﬀ   ects of the most important 
substances aﬀ   ecting equilibrium: sodium, potassium, 
calcium and magnesium minus chloride and lactate. In 
this approach, the apparent SID is deﬁ  ned as follows (see 
Figure 1):
Apparent SID = ([Na+] + [K+]) – ([Cl–] + [lactate])
Th  e two acid–base equilibrium approaches are mathe-
matically equivalent but are completely diﬀ  erent from a 
conceptual point of view. Both are subject to criticism. 
Th  e Stewart approach has been criticised for incor  por-
ating bicarbonate as a dependent variable, the result of a 
calculation, while it is obvious that physiologically 
bicarbonate plays a central role and is regulated mainly 
by the kidneys. Conversely, the Henderson–Hasselbalch 
approach is centred on bicarbonate, which may reﬂ  ect 
the physiological reality better. In the dilution concept, 
metabolic acidosis following resuscitation with large 
volumes of isotonic saline is attributed to dilution of 
serum bicarbonate. Th  e Stewart approach rejects this 
explanation, however, and oﬀ   ers an alternative that is 
based on a decrease in SID. Th   is mechanistic explanation 
is questioned by several authors for fundamental 
chemical reasons [10,11]. If correct, the Stewart approach 
is valid at the mathematical level but does not provide 
mechanistic insights. Th  e quantiﬁ   cation and categori-
sation of acid–base disorders using the Stewart approach, 
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some complex disorders.
Th   e intra-erythrocyte and interstitial space buﬀ  ers are 
not taken into account in either approach. Th  ese  buﬀ  ers 
play a major role in acid–base equilibrium and must be 
included, particularly in the case of isotonic saline 
administration [12] (Figure 2).
Th  e most important consideration is the cause of the 
acidosis. Acidosis is often the consequence of a physio-
logical disturbance or an iatrogenic event. Th  e  diﬃ   culty 
lies in separating the eﬀ   ects of the pathophysiology 
driving the acidosis. For example, metabolic acidosis can 
be a sign of organ distress due to hypoperfusion or 
hypoxia (for example, shock, ketoacidosis or kidney 
disease) [3]. Th  is will produce profound physiological 
eﬀ  ects that are all readily ascribed to the acidosis rather 
than to its cause. Correction of the pathology may correct 
the acidosis, but correction of the acidosis solely is 
unlikely to aﬀ  ect the pathology. Th   erefore it is important 
to understand the mechanism causing the acidosis.
Defi  nitions
In the present article, in an attempt to better describe 
disorders and solutions, we have used the following 
terms.
Dilutional-hyperchloraemic acidosis
Th  e term dilutional-hyperchloraemic acidosis is used 
instead of dilutional acidosis or hyperchloraemic meta-
bolic acidosis, in order to reconcile both theories 
(Henderson–Hasselbalch and Stewart). In reality, many 
articles on hyperchloraemic metabolic acidosis do not 
report SID changes and only mention base excess 
variations and chloride concentrations.
Isotonic saline
Isotonic saline describes the main property of 0.9% saline 
solution. Th  e solution is neither normal, abnormal nor 
unbalanced. Sodium and chloride are partially active, the 
osmotic coeﬃ   cient being 0.926. Th   e actual osmolality of 
0.9% saline is 287 mOsm/kg H2O, which is exactly the 
same as the plasma osmolality.
Balanced solutions
Used generally to describe diﬀ  erent solutions with diﬀ  er-
ent electrolyte compositions close to plasma compo  sition, 
balanced solutions are neither physiological nor plasma-
adapted. Table 1 presents the electrolyte compo  sition of 
commonly available crystalloids. Table 2 presents the 
electrolyte composition of commonly used colloids.
Quantitative eff  ects of isotonic saline infusion on 
acid–base equilibrium
Th  e eﬀ  ects of isotonic saline infusion are illustrated by 
Rehm and Finsterer in patients awaiting intra-abdominal 
surgery [13]. Patients received 40 ml/kg/hour of 0.9% 
isotonic saline, a total of 6 litres isotonic saline in 2 hours. 
Th  e apparent SID decreased from 40 to 31 mEq/l, 
chloride signiﬁ  cantly increased from 105 to 115 mmol/l 
and a decrease in base excess of approximately 7 mmol/l 
was observed. Th   ese data perfectly illustrate 
Figure 1. Representation of the Stewart model. Charge balance 
in blood plasma. Any diff  erence between apparent strong ion 
diff  erence (SIDa) and eff  ective strong ion diff  erence (SIDe) is the 
strong ion gap (SIG) and presents unmeasured anions. The SIG 
should not be confused with the anion gap (AG). A corrected AG can 
be calculated to account for variations in albumin concentration. 
Adapted from Stewart [6].
Figure 2. Plasma bicarbonate concentration versus relative 
haemoglobin after acute haemodilution in diff  erent patient 
groups. Plasma bicarbonate (HCO3
–) concentration (mmol/l) 
versus relative haemoglobin (Hb) (%) after acute normovolaemic 
haemodilution in diff  erent patient groups. Comparison is shown 
for predicted (open squares) and reported (fi  lled circles) values [18] 
of the actual HCO3
– concentration (top curve), composed of the 
calculated HCO3
– values (fi  lled triangles) from plasma dilution, plus 
the increments from the plasma proteins (Pr), the erythrocytes (E), 
and the interstitial fl  uid (ISF) with corresponding buff  ers. Adapted 
from Lang and Zander [12].
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large volumes of isotonic saline in clinical practice. 
Before determining the clinical relevance of dilutional 
hyperchloraemic acidosis, it is important to quantify the 
respective contribution of crystalloids and colloids.
Several studies have reported the biological eﬀ  ects 
following infusion of crystalloids alone [14,15]. Boldt and 
colleagues provide an interesting illustration of the 
eﬀ  ects following infusion of very high doses of crystalloid 
(isotonic saline versus Ringer’s lactate) [16]. In patients 
undergoing major abdominal surgery, they reported the 
intraoperative infusion of 8 litres of crystalloids, followed 
by a further 10 litres of postoperative infusion in 48 hours 
(Table 3), resulting in a total dose of 18 litres of either 
Ringer’s lactate or isotonic saline. As shown in Table 3, 
these extreme doses of isotonic saline were associated 
with moderate and transient eﬀ   ects on acid–base 
equilibrium: a decrease in base excess of 5 mmol/l that 
lasted for 1 or 2 days.
A number of studies have also reported and compared 
the eﬀ   ects following the infusion of large volumes of 
colloids and crystalloids with isotonic saline or balanced 
solutions [17-22].
In patients undergoing abdominal surgery, Boldt and 
colleagues used colloid (HES 130/0.42) either in a 
balanced solution or in an isotonic saline solution. In this 
study, a total balanced ﬂ  uid therapy (colloid and crystal-
loid) was compared with a total isotonic saline-based 
strategy [18]. It is interesting to note that, despite the 
large volumes of ﬂ  uid used (>6 litres), the diﬀ  erence in 
chloride concentration was +8 mmol/l and the diﬀ  erence 
in base excess was –5 mmol/l between the groups 
(Table 4). Th  ese changes were similar to or lower than 
those in other studies (Table 4).
O’Dell and colleagues established that there is an 
inverse linear relationship between chloride load and 
base excess [23]. According to this relationship, to 
decrease base excess by 10 mmol/l in a typical 70 kg 
Table 1. Electrolyte composition (mmol/l) of commonly available crystalloids
Electrolyte  Plasma  0.9% NaCl  Ringer’s lactate, Hartmann’s  Plasma-Lyte® Sterofundin®
Sodium  140 154 131 140 140
Potassium  5 0 5 5 4
Chloride  100 154 111  98  127
Calcium  2.2  0 2 0  2.5
Magnesium  1 0 1  1.5  1
Bicarbonate  24  0 0 0 0
Lactate  1  0 29 0  0
Acetate  0 0 0  27  24
Gluconate  0 0 0  23  0
Maleate  0 0 0 0 5
Plasma-Lyte® from Baxter International (Deerfi  eld, IL, USA). Sterofundin® from B Braun (Melsungen, Germany).
Table 2. Electrolyte composition (mmol/l) of commonly available colloids
       Voluven®  Venofundin®  Hextend®  Volulyte®  PlasmaVolume®  Tetraspan®
        (waxy maize  (potato  (waxy maize  (waxy maize  (potato  (potato
  Albumin  Plasmion®    HES 6%   HES 6%   HES 6%   HES 6%   HES 6%   HES 6% 
  4% Geloplasma®  Gelofusine®  130/0.40) 130/0.42) 670/0.75) 130/0.40) 130/0.42) 130/0.42)
Sodium  140  150  154  154 154 143 137 130 140
Potassium  0  5  0  0 0 3 4  5.4  4.0
Chloride  128  100  125  154 154 124 110 112 118
Calcium  0  0  0  0  0 2.5 0 0.9  2.5
Magnesium  0  1.5  0  0  0 0.5  1.5 1 1.0
Bicarbonate  0  0  0  0 0 0 0 0 0
Lactate  0  30  0  0 0  28  0 0 0
Acetate  0 0 0 0  0  0  34  27  24
Malate  0  0  0  0 0 0 0 0 5
Octanoate  6.4  0  0  0 0 0 0 0 0
HES, hydroxyethyl starch. Gelofusine®, Venofundin® and Tetraspan® from B Braun (Melsungen, Germany). Plasmion®, Geloplasma®, Voluven® and Volulyte® from 
Fresenius-Kabi (Bad Homburg, Germany). Hextend® from BioTime Inc. (Berkeley, CA, USA). PlasmaVolume® from Baxter International (Deerfi  eld, IL, USA).
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chloride – equivalent to around 9 litres of isotonic saline. 
Putting this in the context of the normal maximum doses 
of colloids, infusion of 50 ml/kg HES 130/0.4 would 
reduce base excess by a maximum of 3.5 mmol/l, which 
largely corresponds with observations in published studies. 
Overall, these studies suggest that when patients are 
treated with a combination of isotonic saline-based 
colloids and crystalloids, the eﬀ  ects on acid–base equili-
brium are limited.
Base and colleagues used a diﬀ  erent ﬂ  uid strategy in 
patients undergoing cardiac surgery. HES 130/0.4 was 
administered either in a balanced solution or a saline 
solution. Th   e two groups also received the same balanced 
crystalloid, Ringer’s lactate [17]. Th  e chloride concen-
tration at the end of surgery was 110 mmol/l in the group 
receiving HES in a balanced solution, compared with 
112  mmol/l in the isotonic saline-based solution. Th  e 
diﬀ  erence is statistically signiﬁ  cant but is not clinically 
relevant. Base excess decreased in both groups, but the 
maximum diﬀ   erence between the groups at any time 
point was around 2 mmol/l.
Th   e respective role of crystalloids and colloids on acid–
base equilibrium is perfectly illustrated by Boldt and 
colleagues in elderly patients undergoing abdominal 
surgery [24]. Th  ree  diﬀ  erent strategies were used: Ringer’s 
lactate, isotonic saline, and HES 130/0.4 plus Ringer’s 
lactate. Th   e chloride and sodium loads and the eﬀ  ect on 
base excess are shown in Figure 3. Although the colloid 
used in this study was supplied in an isotonic saline 
carrier, overall the impact on base excess was similar to 
that of Ringer’s lactate alone and remained within the 
normal range.
Overall, these studies suggest that large volumes of 
saline will increase the chloride concentration and reduce 
base excess in a dose-dependent manner, with the peak 
eﬀ  ect occurring a few hours post infusion. Th  e  eﬀ  ect is 
temporary, and levels generally return to normal within 1 
or 2 days. When ﬂ  uid therapy is based on colloids in an 
isotonic saline carrier, together with a balanced crystal-
loid like Ringer’s lactate, the eﬀ  ects on acid–base equili-
brium appear limited. Owing to a lack of published 
clinical experience, it remains to be seen whether patients 
with pre-existing metabolic acidosis are more aﬀ  ected 
due to a reduced buﬀ  ering capacity. Transient isotonic 
saline-induced reduction of base excess should be 
considered when interpreting the acid–base status in 
unstable patients.
Is dilutional-hyperchloraemic acidosis clinically 
relevant?
While it is clear that dilutional-hyperchloraemic acidosis 
exists, it is important to examine whether it has any eﬀ  ect 
on organ function. Th   e kidney, gastrointestinal tract and 
coagulation system have often been mentioned as 
possible targets.
Eff  ects of dilutional-hyperchloraemic acidosis on renal 
function
Animal studies suggest that chloride may have eﬀ  ects on 
the kidney including renal vasoconstriction, an increase 
in renal vascular resistance, a decrease in glomerular 
ﬁ  ltration rate and a decrease in renin activity [25-28]. At 
normal and slightly high concentrations, however, the 
eﬀ  ects are small [29].
Diﬀ  erences in osmolarity between Ringer’s lactate and 
isotonic saline have to be taken into account to 
understand the eﬀ   ects on renal function and urine 
output. Th   e osmolarity of Ringer’s lactate is 273 mOsm/l. 
In dilute physiological solutions, the values of osmolality 
Table 3. Total volume input and urine output: eff  ects on chloride and base excess [16]
       First  Second
    After surgery  5 hours on ICU  postoperative day  postoperative day (total)
Cumulative volume input (ml)       
  Ringer’s lactate  7,950 ± 950  9,070 ± 920  14,150 ± 1,150  18,750 ± 1,890
  Saline solution  8,230 ± 580  9,550 ± 880  13,790 ± 1,650  17,990 ± 1,790
Cumulative urine output (ml)       
  Ringer’s lactate  1,950 ± 340  4,400 ± 410  7,700 ± 370  11,450 ± 460
  Saline solution  2,250 ± 240  3,920 ± 350  6,950 ± 430  12,940 ± 390
Cl–  (mmol/l)     
  Ringer’s lactate  104 ± 3  105 ± 3  102 ± 2  102 ± 3
  Saline solution  113 ± 4*†  111 ± 3*†  111 ± 3*†  106 ± 5
Base defi  cit (mmol/l)       
  Ringer’s lactate  –0.5 ± 0.6  –1.0 ± 1.2  2.0 ± 0.5  2.9 ± 1.1
  Saline solution  –5.6 ± 2.1*†  –4.2 ± 1.9*†  –2.8 ± 1.1*†  0.3 ± 1.5*
ICU, intensive care unit. *P <0.05 diff  erence compared with the other group. †P <0.05 diff  erence compared with baseline values.
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osmolality of Ringer’s lactate is only 254 mOsm/kg. Th  is 
discrepancy is due to incomplete ionisation of the solutes 
in Ringer’s lactate. On the contrary, isotonic saline, which 
is completely ionised, has an osmolality similar to the 
calculated osmolarity of 308 mOsm/l. Compared with 
the osmolality of normal serum (285 to 295 mOsm/kg), 
therefore, Ringer’s lactate is clearly hypotonic while 0.9% 
saline is isotonic.
In a study with human volunteers, Williams and 
colleagues tested the hypothesis that infusion of large 
volumes of Ringer’s lactate or isotonic saline may have 
diﬀ  erent eﬀ  ects on renal function and urine output [15]. 
Th  ere was a signiﬁ  cant  diﬀ   erence in mean time to 
urination, Ringer’s lactate solution being associated with 
the shorter time to ﬁ   rst urine output. In fact, in the 
Ringer’s lactate group a decrease in serum osmolality 
probably inhibited the release of antidiuretic hormone. 
Th  e resulting diuresis of hypotonic urine causes the 
serum osmolality to return quickly to normal.
Th   ese changes in osmolarity must be taken into account 
in the interpretation of clinical studies comparing 
Ringer’s lactate with isotonic saline. In a similar study by 
Reid and colleagues, time to ﬁ  rst micturition was shorter 
in the Ringer’s lactate group, and was associated with a 
decreased urine osmolarity [30]. Th  is suggests that the 
Table 4. Eff  ects on base excess and chloride concentrations from diff  erent clinical studies
        Volumes  Minimal value  Maximal change
        infused during  in base excess  in chloride
Study  Setting   Infusion strategy  study period (ml)  (mmol/l)  (mmol/l)
Boldt and colleagues [18]  Abdominal surgery  Balanced group    <1a +3a
      HES 130/0.42  3,866 ± 1,674   
      Modifi  ed RL  5,966 ± 1,202   
  Saline-based  group    –5a +8a
      HES 130/0.42  3,533 ± 1,302
      Isotonic saline   5,333 ± 1,063   
Kulla and colleagues [21]  Abdominal surgery  Balanced    –1.8  +3
      HES 130/0.42   1,923 ± 989   
      Modifi  ed RL  4,268 ± 999   
  Saline-based    –4.2  +5
      HES 130/0.42   1,828 ± 522   
      Modifi  ed saline   4,490 ± 1,126   
Boldt and colleagues [19]  Cardiac surgery  Balanced    –1.2  Not reported
      HES 130/0.42   2,750 ± 640   
      Modifi  ed RL  5,200 ± 610   
  Saline-based    –4.4  Not  reported
      HES 130   2,820 ± 550   
      Isotonic saline  5,150 ± 570   
Boldt and colleagues [20]  Cardiopulmonary bypass   Balanced    0a Not  reported
      HES 130/0.42  3,090 ± 540   
      Modifi  ed RL  4,010 ± 410   
  Saline-based    –6a Not  reported
      5% albumin   3,110 ± 450   
      Isotonic saline  5,450 ± 560   
Boldt and colleagues [22]  Cardiopulmonary bypass   Balanced    –1a Not  reported
      HES 130/0.40  2,950 ± 530   
      Modifi  ed RL  5,090 ± 750   
  Saline-based    –5a Not  reported
      5% albumin   3,050 ± 560   
      Isotonic saline  5,050 ± 680   
HES, hydroxyethyl starch; RL, Ringer’s lactate. aValues estimated from fi  gures reported in the article.
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their study, the isotonic saline group retained a greater 
proportion of the sodium load than did the Ringer’s 
lactate group, which may account for the diﬀ  erence in 
ﬂ  uid retention. Th  ese results emphasise that diﬀ  erences 
in osmolality between balanced solutions and isotonic 
saline must be taken into account in the interpretation of 
renal function parameters such as time to micturition 
and urine output.
O’Malley and colleagues compared Ringer’s lactate 
with isotonic saline in patients undergoing renal trans-
plantation. Th  is study found that recipients undergoing 
kidney transplants had greater acidosis and higher 
potassium concentrations if they were given isotonic 
saline as opposed to Ringer’s lactate [31]. Th  ese eﬀ  ects 
are the consequence of acidosis mobilising potassium 
from the intracellular space in patients where renal 
function is unable to compensate for these changes. It is 
worth noting that there was no adverse eﬀ  ect of isotonic 
saline on renal function. Th  ere is no evidence of this 
eﬀ   ect in other studies comparing isotonic saline with 
balanced salt crystalloids [31].
Boldt and colleagues published a series of articles in 
which a totally balanced strategy (balanced crystalloid 
and balanced colloid) was compared with a standard 
treatment (isotonic saline and colloid in isotonic saline 
carrier) (Table 4). In one study, in patients undergoing 
major abdominal surgery there was no signiﬁ  cant 
diﬀ  erence in urine output and in serum creatinine on the 
ﬁ  rst postoperative day [18].
Another study in elderly patients undergoing cardiac 
surgery also reported no major impact on renal function 
[19]. For up to 60 days following surgery, there was no 
diﬀ  erence between the groups regarding plasma creati-
nine concentration. Levels of neutrophil gelatinase-asso-
ciated lipocalin (NGAL) were also measured. Th   ere was a 
small increase on the ﬁ  rst day after surgery in the isotonic 
saline-based group, but levels in both groups were near-
normal by the second day. Overall NGAL values were 
extremely low (around 20 ng/ml), signiﬁ  cantly below the 
threshold of 150 ng/ml that is considered an indicator of 
acute kidney injury.
Finally, a study investigating the eﬀ  ects of two colloid 
strategies in patients undergoing cardiopulmonary 
Figure 3. Chloride load and base excess in elderly patients undergoing abdominal surgery. Chloride load in the three groups of patients – 
Ringer’s lactate group (fi  lled circles), isotonic saline group (fi  lled squares), and HES 130/0.4 plus Ringer’s lactate (open triangles) – was calculated. 
The variations in base excess for the three groups are shown graphically. It is remarkable that there is no diff  erence between the Ringer’s lactate 
group and the HES 130/0.4 plus Ringer’s lactate group. *P <0.05. POD, postoperative day. Adapted from Boldt and colleagues [24].
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Albumin in saline carrier was compared with an HES-
based colloid in balanced solution. Th   ere was no signiﬁ  -
cant diﬀ   erence in serum creatinine following surgery; 
and although an increase in NGAL of 15 ng/ml was 
observed in the albumin group, values remained within 
the normal range.
It has been claimed that NGAL is an early biomarker of 
acute renal injury [32], but NGAL values can vary 
considerably even in the absence of adverse kidney 
eﬀ   ects. Using the same test as was used in the two 
previously mentioned studies, Wagener and colleagues 
reported rises of 165 to 1,490 ng/ml in cardiac surgery 
patients with and without acute kidney injury [33]. Th  ese 
results suggest that values reported by Boldt and 
colleagues are very low and, although the type of solution 
signiﬁ  cantly  inﬂ   uenced the NGAL values, there is no 
indication of signiﬁ  cant impairment in renal function.
In conclusion, no signiﬁ  cant diﬀ  erences in creatinine 
variations have been reported and only slight diﬀ  erences 
in NGAL, not clinically relevant, were observed. From 
these results one may conclude there is no convincing 
diﬀ  erence between isotonic saline strategies and balanced 
strategies in terms of renal function.
Eff  ects of dilutional-hyperchloraemic acidosis on 
coagulation and bleeding
Data from in vitro studies suggest that balanced solutions 
may have fewer negative eﬀ   ects on coagulation para-
meters [34,35]. Th  e authors acknowledge the inherent 
problems of in vitro studies, however, which include the 
eﬀ   ects of haemodilution, calcium dilution and the 
absence of physiological components such as the endo-
thelium. Owing to these signiﬁ   cant limitations, no 
clinically relevant conclusions can be drawn from in vitro 
studies.
Clinical studies provide more relevant insights. Boldt 
and colleagues compared the eﬀ  ects of very high doses 
(around 18 litres in 48 hours) of Ringer’s lactate and 
isotonic saline in patients undergoing abdominal surgery 
(Table 3) [16]. Th  ere was no signiﬁ  cant  diﬀ  erence  in 
coagulation tests and in blood loss between the groups.
Waters and colleagues compared Ringer’s lactate with 
isotonic saline in patients undergoing repair of abdominal 
and thoracoabdominal aortic aneurysm (Table 5) [36]. 
Th   ere was a small but nonsigniﬁ  cant diﬀ  erence in blood 
loss in favour of the Ringer’s lactate group (Table 5). 
Th   ere was no signiﬁ  cant diﬀ  erence in the use of packed 
red blood cells or fresh-frozen plasma between the two 
groups. Th   e only statistically signiﬁ  cant diﬀ  erence was a 
higher volume of platelet transfusion in the saline group. 
When all blood products were summed, the use of blood 
products was signiﬁ   cantly higher in the saline group. 
Both groups included patients with thoracoabdominal 
aneurysm, however, which may account for the high 
variability in blood loss and transfusion requirements. 
No signiﬁ  cant diﬀ  erence in morbidity or mortality was 
reported.
Studies investigating the use of colloids also found no 
diﬀ   erence in blood loss between colloids in balanced 
solutions and those in isotonic saline solutions. Kulla and 
colleagues did not observe diﬀ   erences in blood loss 
patients undergoing abdominal surgery, and all other 
coagulation parameters were not signiﬁ  cantly diﬀ  erent 
between the two groups [21]. A similar study by Boldt 
and colleagues also found no diﬀ   erence in blood loss 
between the two groups (Table 5) [18].
Only one study reported diﬀ  erences between isotonic 
saline-based and balanced colloids. Comparing HES 
130/0.42 in balanced solution with albumin in saline as a 
priming solution for cardiopulmonary bypass, Boldt and 
colleagues reported small but signiﬁ  cant diﬀ  erences in 
coagulation (Rotem, Pentapharm, Munich, Germany) in 
favour of the balanced HES. Th  is observation was 
associated with signiﬁ   cantly lower blood loss [20]. 
Similarly, use of blood products throughout and after 
surgery was signiﬁ   cantly lower in the HES group 
(Table 5). Th   e number of patients in each group was very 
small (n = 25), however, given that coagu  lation and bleed-
ing in cardiac surgery may be highly variable. A recent 
study performed by the same investi  gators in the same 
setting (cardiac surgery), comparing a balanced HES with 
albumin, did not conﬁ  rm these results [22].
In conclusion, there is little evidence that large volumes 
of isotonic saline have a signiﬁ  cantly detrimental eﬀ  ect 
on coagulation, blood loss or transfusion.
Eff  ects of dilutional-hyperchloraemic acidosis on 
gastrointestinal function
Several studies have investigated the eﬀ  ects of dilutional-
hyperchloraemic acidosis on gastrointestinal function 
with controversial results.
Williams and colleagues reported that healthy volun-
teers receiving saline experienced more frequent abdo-
minal discomfort than those receiving Ringer’s lactate 
[15]. Wilkes and colleagues investigated the eﬀ  ects of 6% 
hetastarch in a balanced carrier plus Ringer’s lactate 
versus hetastarch in saline plus isotonic saline in elderly 
surgical patients [37]. Th  e only diﬀ   erence related to 
gastrointestinal function was a small diﬀ  erence in the 
gastric CO2 gradient, which showed a larger increase in 
the saline group. Th  e  diﬀ  erence is small and probably not 
clinically relevant (0.3 ± 1.5 kPa in the Ringer’s lactate 
group compared with 1.0 ± 0.7 kPa in the saline group), 
but may suggest a better gastric mucosal perfusion in the 
Ringer’s lactate group. A nonsigniﬁ  cant trend towards 
more nausea and vomiting was observed in the saline 
group.
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Patients were randomised into three groups to compare 
the eﬀ  ects of hetastarch in isotonic saline, of hetastarch 
in balanced solution and of Ringer’s lactate on post-
operative outcomes [38]. While there was no signiﬁ  cant 
diﬀ  erence in the incidence of nausea and use of anti-
emetics between the hetastarch groups, both were 
signiﬁ     cantly lower than in the Ringer’s lactate group 
(Table 6). Th   e authors concluded that intraoperative ﬂ  uid 
resuscitation with colloids, compared with crystalloids, 
improved postoperative recovery with regards to post-
operative nausea and vomiting. Th   ese results suggest that 
ﬂ  uid volume may be more important than composition. 
Several other studies suggest that intraoperative crystal-
loid restriction may be associated with an improve  ment 
in gastrointestinal function and a decrease in post-
operative complications [39-41].
In conclusion, there is not suﬃ   cient evidence from the 
available literature to suggest that dilutional-hyper-
chloraemic acidosis has a clinically relevant eﬀ  ect  on 
gastrointestinal function. Some degree of intraoperative 
crystalloid restriction and colloid use may, however, be 
associated with an improvement in gastrointestinal 
function and outcome.
Eff  ects of dilutional-hyperchloraemic acidosis on mortality
Metabolic acidosis is often associated with adverse 
outcomes; however, it is important to diﬀ  erentiate 
between the eﬀ  ects of acidosis itself and the conditions 
that cause it. In the clinical setting, metabolic acidosis 
arises from diﬀ   erent causes, within which hyper-
chloraemia may play a role. Following trauma, for example, 
major metabolic acidosis has been reported in relation to 
severe hypovolaemia, tissue hypoxia and shock. In this 
situation, it is very diﬃ   cult to determine the speciﬁ  c role of 
isotonic saline administration and the potential impact of 
other mechanisms on outcome [42-45].
Experimental studies may therefore be useful to under-
stand the impact of ﬂ  uid therapy on outcome. Short-term 
survival was measured in a model of experimental sepsis 
with rats resuscitated with a balanced hetastarch, Ringer’s 
lactate or isotonic saline [46]. In terms of mortality, 
Ringer’s lactate was no better than isotonic saline. Th  e  best 
survival was observed in the colloid group, suggesting 
that a colloid strategy may be favourable in sepsis.
Gunnerson and colleagues carried out an observational, 
retrospective review of hospital data of 9,799 critically ill 
patients admitted to the intensive care unit [47]. Th  ey 
selected a cohort (n = 851) in which clinicians ordered a 
measurement of arterial lactate level; 584 patients (64%) 
had a metabolic acidosis, either related to lactate, a 
strong ion gap or hyperchloraemia. Mortality was highest 
in patients with lactate acidosis (56%). In patients with 
dilutional-hyperchloraemic acidosis, mortality was the 
same as in the control group without metabolic acidosis 
(Figure 4). From this observational study, it may be 
concluded that patients with hyperchloraemic acidosis 
were not associated with an increased risk of mortality 
compared with critically ill patients without metabolic 
acidosis.
Table 5. Blood loss in studies comparing a balanced strategy with a saline-based strategy
Study  Group  Blood loss (ml)  P value between groups
Crystalloids only     
  Waters and colleagues [36]  Ringer’s lactate  2,300 (1,600 to 3,500)  NS
    Isotonic saline  2,900 (1,930 to 4,000) 
  Boldt and colleagues [16]  Ringer’s lactate  1,830 ± 380  NS
    Isotonic saline  1,730 ± 390 
Colloids and crystalloids     
  Kulla and colleagues [21]  HES 130/0.42 + Ringer’s acetate  1,156 ± 917  NS
    HES 130/0.42 + modifi  ed saline  1,228 ± 691 
  Boldt and colleagues [18]  HES 130/0.42 + modifi  ed RL  1,798 ± 1,220  NS
    HES 130/0.42 + isotonic saline  1,557 ± 1,165 
  Boldt and colleagues [19]  HES 130/0.42 + modifi  ed RL  1,510 ± 410  NS
    HES 130/0.42 + isotonic saline  1,380 ± 460 
  Boldt and colleagues [20]  HES 130/0.42 + modifi  ed RL  1,200 ± 290  <0.05
    Albumin 5% + isotonic saline  1,520 ± 210 
  Boldt and colleagues [22]  HES 130/0.40 + modifi  ed RL  1,380 ± 460  NS
    Albumin 5% + isotonic saline  1,510 ± 410 
HES, hydroxyethyl starch; RL, Ringer’s lactate.
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study in 60 patients with severe sepsis and septic shock 
[48]. In this group of patients, mortality was signiﬁ  cantly 
associated with an increased inorganic ion diﬀ  erence. 
Th  e  diﬀ   erence in plasma chloride concentrations 
between survivors and nonsurvivors was minimal 
(3 mEq/l). Of note in the Rivers study, a diﬀ  erence in base 
excess of 5 mEq/l after 6 hours of treatment was observed 
between optimised patients and controls, with a conco-
mitant reduced mortality in the patients receiving the 
highest dose of colloids and crystalloids (6 litres versus 
4.5 litres) [49]. In their study, however, several confound-
ing variables might have inﬂ  uenced the acid–base status 
and the mortality is more related to the cause of acidosis 
rather than to transient  dilutional-hyperchloraemic 
acidosis.
In a prospective observational study set in the 
paediatric intensive care unit following cardiac surgery, 
Hatherill and colleagues documented that dilutional-
hyperchloraemic acidosis was associated with reduced 
requirement for adrenaline therapy [50]. It is suggested 
that dilutional-hyperchloraemic acidosis is a benign 
phenomenon that should not prompt escalation of 
haemodynamic support.
In another prospective observational trial, Brill and 
colleagues studied 75 consecutive surgical intensive care 
patients with base deﬁ   cits >2.0 mmol/l. Patients were 
divided into those with hyperchloraemic acidosis and 
those with acidosis from other causes. Th  ere were no 
signiﬁ  cant  diﬀ   erences in age, Acute Physiology and 
Chronic Health Evaluation II scores, or volumes of 
resuscitation between the hyperchloraemic group and 
the remaining patients. Th   ere were four deaths (10.8%) in 
the hyperchloraemic group and 13 deaths (34.2%) in the 
remaining patients (P = 0.03). Th   e authors concluded that 
hyperchloraemic acidosis is a common cause of base 
deﬁ  cit in the surgical intensive care unit, associated with 
lower mortality than base deﬁ  cit secondary to another 
cause [51]. Maciel and Park have reported similar results 
[52].
Conclusion
Th   e current review has presented an extensive analysis of 
all available studies using balanced solutions. We 
conclude that dilutional-hyperchloraemic acidosis is a 
side eﬀ  ect, mainly observed after the administration of 
large volumes of isotonic saline as a crystalloid. In this 
particular setting, however, the eﬀ  ect remains moderate 
Table 6. Incidence and severity of postoperative complications [38]
Variable  6% hetastarch in saline  6% hetastarch in balanced salt  Ringer’s lactate  P value
Nausea  14 (47%)  11 (37%)  22 (73%)  0.007
Nausea severity       
 1  (mild)  8  2  4  0.02
 2  (moderate)  4  4  10 
 3  (severe)  2  5  8 
Emesis  8 (27%)  7 (23%)  16 (53%)  0.02
Rescue antiemetic  9 (30%)  8 (27%)  18 (60%)  0.006
Figure 4. Hospital mortality associated with type of metabolic acidosis. Mortality associated with the major ion contributing to the metabolic 
acidosis. Hospital mortality associated with the various causes of metabolic acidosis (standard base excess (SBE) <–2). Mortality percentage is 
mortality within each subgroup, not a percentage of overall mortality. Lactate indicates that lactate contributes to at least 50% of the SBE; SIG, 
strong ion gap contributes to at least 50% of SBE (and not lactate); hyperchloraemic, absence of lactate or SIG acidosis and SBE <–2; none, no 
metabolic acidosis (SBE ≥–2 mEq/l). P <0.001 for the four-group comparison. Adapted from Gunnerson and colleagues [47].
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with the use of olloids, whatever the nature of the carrier. 
From the available literature, the evidence for adverse 
eﬀ  ects of dilutional-hyperchloraemic acidosis on organ 
function, morbidity or mortality remains of small 
importance. In addition, the use of colloids together with 
crystalloids allows a reduction of the total volume of 
ﬂ  uids used and considerably limits the chloride load.
In view of the substantial experimental and clinical 
information on the eﬃ   cacy and safety of various colloids, 
including third-generation HES (HES 130/0.4), and of the 
limited published information on the eﬀ  ects of balanced 
solutions on outcome, we cannot changing to a new 
generation of colloids until there is evidence suggesting 
genuine detriment from existing ﬂ  uids and clear evidence 
of beneﬁ  t with new solutions.
Key messages
• Th   e term dilutional-hyperchloraemic accurately deﬁ  nes 
a decrease in base excess, or a decrease in SID, asso-
ciated with hyperchloraemia and a normal anion gap.
• Isotonic saline describes the main property of 0.9% 
saline solution. It is neither normal, abnormal nor 
unbalanced. Balanced solutions is a general term to 
describe diﬀ  erent solutions with diﬀ  erent electrolyte 
compositions.
•  Dilutional-hyperchloraemic acidosis is a moderate and 
relatively transient side eﬀ  ect, minimised or avoided by 
limiting crystalloid administration through the use of 
colloids in any carrier.
•  No convincing evidence for clinically relevant adverse 
eﬀ   ects of dilutional-hyperchloraemic acidosis on 
morbidity or mortality can be found.
•  Following extensive review, owing to the limited pub-
lished information on the eﬀ  ects of balanced solutions 
on outcome, the change of practice from colloids in 
isotonic saline to balanced colloid use cannot be 
recom mended.
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